IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.459. It has been cited 8 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.129
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
National Institutes of Health
Grant: R01CA115611
National Institutes of Health
Grant: R37CA218072
Leukemia and Lymphoma Society
Grant: 6076-14
Cincinnati Cancer Center
Grant: Affinity Group Award
Cincinnati Children's Innovation Fund
Grant: FY19
FWCI
0.38
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals